EyePoint Pharmaceuticals vs Ray Therapeutics
EyePoint Pharmaceuticals vs Ray Therapeutics, compared side by side on 16 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: EyePoint Pharmaceuticals is on 36/100 and Ray Therapeutics on 53/100.
Where each one leads
EyePoint Pharmaceuticals
- agent readiness: 50/100 against 21/100
- domain rating: 43/100 against 29/100
- funding raised: $436M against $243M
Ray Therapeutics
- our overall score: 53/100 against 36/100
At a glance
| Measure | EyePoint Pharmaceuticals | Ray Therapeutics |
|---|---|---|
| What it is | Ophthalmology-focused biopharmaceutical company developing sustained-release drug delivery systems for serious eye diseases. | Pioneering vision restoration therapies for severe retinal degenerations. |
| Category | Biotechnology, Biopharmaceuticals, Specialty Pharmaceuticals, Ophthalmology | Biotechnology, Pharmaceuticals, Healthcare, Medical Devices |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | hardware | services | marketplace | platform | Services |
| Founded | 1987 | 2021 |
| Headquarters | Watertown, United States | Berkeley, USA |
| Status | Inactive | Active |
Size, funding and growth
| Measure | EyePoint Pharmaceuticals | Ray Therapeutics |
|---|---|---|
| Total funding | $436M | $243M |
| Latest round | Public Offering | Series B |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | EyePoint Pharmaceuticals | Ray Therapeutics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 36/100 | 53/100 |
| Traction | 40/100 | 40/100 |
| Team | 30/100 | 50/100 |
| Search visibility | 13/100 | 14/100 |
| Quality | 40/100 | 68/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (50/100) | F (21/100) |
| Domain ratingLink authority, 0-100 | 43/100 | 29/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | EyePoint Pharmaceuticals | Ray Therapeutics |
|---|---|---|
| Hosting | Google Cloud | Not detected |
| CDN | Not detected | Cloudflare |
| CMS | Not detected | WordPress |
| Frameworks | Not detected | Jquery |
| Analytics | Not detected | Google Analytics 4 |
EyePoint Pharmaceuticals vs Ray Therapeutics: common questions
Which is better, EyePoint Pharmaceuticals or Ray Therapeutics?
On our 0-100 score Ray Therapeutics rates higher (53/100 against 36/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 16 data points above: read the rows that match what you are buying for.
How do EyePoint Pharmaceuticals and Ray Therapeutics compare on the numbers?
EyePoint Pharmaceuticals leads on agent readiness (50/100 against 21/100), domain rating (43/100 against 29/100), funding raised ($436M against $243M). Ray Therapeutics leads on our overall score (53/100 against 36/100).
Read the full EyePoint Pharmaceuticals review and pricing or the Ray Therapeutics review and pricing. You can also browse other EyePoint Pharmaceuticals alternatives we track.